<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04098055</url>
  </required_header>
  <id_info>
    <org_study_id>SLE</org_study_id>
    <nct_id>NCT04098055</nct_id>
  </id_info>
  <brief_title>Effect of Insoles in Patients With Systemic Lupus Erythematosus</brief_title>
  <acronym>EISLE</acronym>
  <official_title>Effectiveness of Custom-made Foot Orthoses in Patients With Systemic Lupus Erythematous</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Seville</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Seville</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Demonstrate that custom-made insoles improve painful symptomatology, health and foot function
      in subjects with SLE and podiatric involvement.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">November 2, 2019</start_date>
  <completion_date type="Anticipated">November 2, 2021</completion_date>
  <primary_completion_date type="Anticipated">February 2, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>11-point Numeric Pain Rating Scale</measure>
    <time_frame>1 minute</time_frame>
    <description>With a range of 0 = no pain to 10 = pain as bad as it can be.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SF- 12 Quality of Life</measure>
    <time_frame>10 minutes</time_frame>
    <description>To describe the relationships among functional health status measures. This has values between 0 and 100, with higher values corresponding to lower quality of life.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Foot Function</measure>
    <time_frame>5 minutes</time_frame>
    <description>Foot Function Index</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Foot Disability</measure>
    <time_frame>5 minutes</time_frame>
    <description>Manchester Foot Pain and Disability Index</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Lupus Erythematosus, Systemic</condition>
  <condition>Foot Orthoses</condition>
  <condition>Musculoskeletal Pain</condition>
  <arm_group>
    <arm_group_label>Custom-made foot orthoses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Custom-Made Foot Orthoses</intervention_name>
    <description>The foot orthoses were custom made using phenolic foam molds of the feet. They consisted of a polypropylene layer of 2 mm from heel to just proximal to the metatarsal heads, an upper sheet of 30 Shore A polyethylene foam.</description>
    <arm_group_label>Custom-made foot orthoses</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>The insole made using phenolic foam molds of the feet. They consisted of an upper sheet of 30 Shore A polyethylene foam.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years or more.

          -  Medical diagnosis of LES.

          -  Foot involvement.

        Exclusion Criteria:

          -  Treatment with foot orthoses.

          -  LES with acute symptomatic flare.

          -  Ulcers.

          -  Skin involvement.

          -  Neurological problems.

          -  Cognitive deterioration.

          -  Need for walking assistance.

          -  Refused to change footwear to use the foot orthoses.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Pedro V. Munuera-Martínez, PhD.</last_name>
    <phone>+34954486526</phone>
    <email>pmunuera@us.es</email>
  </overall_contact>
  <results_reference>
    <citation>Pipili C, Sfritzeri A, Cholongitas E. Deforming arthropathy in systemic lupus erythematosus. Eur J Intern Med. 2008 Nov;19(7):482-7. doi: 10.1016/j.ejim.2008.01.017. Epub 2008 Apr 1. Review.</citation>
    <PMID>19013374</PMID>
  </results_reference>
  <results_reference>
    <citation>Otter SJ, Kumar S, Gow P, Dalbeth N, Corkill M, Rohan M, Davies KA, Pankathelam S, Rome K. Patterns of foot complaints in systemic lupus erythematosus: a cross sectional survey. J Foot Ankle Res. 2016 Mar 22;9:10. doi: 10.1186/s13047-016-0143-8. eCollection 2016.</citation>
    <PMID>27006702</PMID>
  </results_reference>
  <results_reference>
    <citation>Reina-Bueno M, Vázquez-Bautista MDC, Pérez-García S, Rosende-Bautista C, Sáez-Díaz A, Munuera-Martínez PV. Effectiveness of custom-made foot orthoses in patients with rheumatoid arthritis: a randomized controlled trial. Clin Rehabil. 2019 Apr;33(4):661-669. doi: 10.1177/0269215518819118. Epub 2018 Dec 17.</citation>
    <PMID>30556429</PMID>
  </results_reference>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>September 18, 2019</study_first_submitted>
  <study_first_submitted_qc>September 18, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">September 20, 2019</study_first_posted>
  <last_update_submitted>September 23, 2019</last_update_submitted>
  <last_update_submitted_qc>September 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Seville</investigator_affiliation>
    <investigator_full_name>Pedro V. Munuera-Martínez</investigator_full_name>
    <investigator_title>Director</investigator_title>
  </responsible_party>
  <keyword>Lupus Erythematosus, Systemic</keyword>
  <keyword>Foot Orthoses</keyword>
  <keyword>Foot</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Musculoskeletal Pain</mesh_term>
    <mesh_term>Lupus Erythematosus, Systemic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

